Cytochrome P450 2B6 (CYP2B6) G516T influences Nevirapine Plasma Concentrations in HIV-infected Patients in Uganda

Thumbnail Image
Files
Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda.pdf (79.99 KB)
Date
2007
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
HIV medicine
Abstract
Polymorphisms in the cytochrome P450 (CYP) 2B6 gene have been shown to influence nevirapine plasma concentrations in HIV-infected European Caucasians. Although nevirapine is used extensively in Africa, the influence of CYP2B6 genotype on nevirapine exposure has not been assessed in this population. We aimed to determine the influence of CYP2B6 genotype at position 516 on nevirapine trough concentrations in HIV-infected patients in Kampala, Uganda. Additional polymorphisms in the CYP and multidrug resistance protein-1 (MDR-1) genes were also assessed for their impact on nevirapine concentrations.
Description
Keywords
CYP2B6, HIV, Nevirapine, Pharmacogenomics
Citation
Penzak, S. R., Kabuye, G., Mugyenyi, P., Mbamanya, F., Natarajan, V., Alfaro, R. M., ... & Masur, H. (2007). Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV‐infected patients in Uganda. HIV medicine, 8(2), 86-91.https://doi.org/10.1111/j.1468-1293.2007.00432.x
URI
https://nru.uncst.go.ug/handle/123456789/8330
Collections
Medical and Health Sciences